share_log

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $25

Moomoo 24/7 ·  Mar 6 09:31

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target from $28 to $25.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment